Michael Wen
Clinical Research Coordinator
Psychiatry
School of Medicine

Publications (12)

Top publication keywords:
GlucosePediatric ObesityInsulinUridineMetabolic SyndromeSweetening AgentsIntra-Abdominal FatFructoseAdipose TissueLipogenesisApolipoprotein C-IIIDietDietary CarbohydratesHIV Protease InhibitorsIndinavir

• A quantitative study of vapor diffusions for crystallizations: rates and solvent parameter changes.
  Dalton transactions (Cambridge, England : 2003) 2019 Wen MJ, Jackson MT, Garner CM
• Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity.
  Gastroenterology 2017 Schwarz JM, Noworolski SM, Erkin-Cakmak A, Korn NJ, Wen MJ, Tai VW, Jones GM, Palii SP, Velasco-Alin M, Pan K, Patterson BW, Gugliucci A, Lustig RH, Mulligan K
• Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome.
  Atherosclerosis 2016 Gugliucci A, Lustig RH, Caccavello R, Erkin-Cakmak A, Noworolski SM, Tai VW, Wen MJ, Mulligan K, Schwarz JM
• Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome.
  Obesity (Silver Spring, Md.) 2015 Lustig RH, Mulligan K, Noworolski SM, Tai VW, Wen MJ, Erkin-Cakmak A, Gugliucci A, Schwarz JM
• Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.
  The Journal of clinical endocrinology and metabolism 2015 Schwarz JM, Noworolski SM, Wen MJ, Dyachenko A, Prior JL, Weinberg ME, Herraiz LA, Tai VW, Bergeron N, Bersot TP, Rao MN, Schambelan M, Mulligan K

Show all (7 more) Hide

• Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement.
  PloS one 2011 Weinberg ME, Roman MC, Jacob P, Wen M, Cheung P, Walker UA, Mulligan K, Schambelan M
• Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.
  The Journal of clinical endocrinology and metabolism 2010 Rao MN, Mulligan K, Tai V, Wen MJ, Dyachenko A, Weinberg M, Li X, Lang T, Grunfeld C, Schwarz JM, Schambelan M
• Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity.
  Hepatology (Baltimore, Md.) 2010 Lam KD, Bacchetti P, Abbasi F, Ayala CE, Loeb SM, Shah V, Wen MJ, Reaven GM, Maher JJ, Khalili M
• The acute effects of HIV protease inhibitors on insulin suppression of glucose production in healthy HIV-negative men.
  Journal of acquired immune deficiency syndromes (1999) 2009 Lee GA, Schwarz JM, Patzek S, Kim S, Dyachenko A, Wen M, Mulligan K, Schambelan M, Grunfeld C
• The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.
  The Journal of clinical endocrinology and metabolism 2009 Mulligan K, Khatami H, Schwarz JM, Sakkas GK, DePaoli AM, Tai VW, Wen MJ, Lee GA, Grunfeld C, Schambelan M
• Indinavir increases glucose production in healthy HIV-negative men.
  AIDS (London, England) 2004 Schwarz JM, Lee GA, Park S, Noor MA, Lee J, Wen M, Lo JC, Mulligan K, Schambelan M, Grunfeld C
• Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation.
  The Journal of clinical endocrinology and metabolism 2002 Schwarz JM, Mulligan K, Lee J, Lo JC, Wen M, Noor MA, Grunfeld C, Schambelan M